Bret Scholtes's most recent trade in Guardion Health Sciences Inc was a trade of 37,175 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on Jan. 6, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Guardion Health Sciences Inc | Bret Scholtes | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 06 Jan 2022 | 37,175 | 294,980 (0%) | 0% | 0.7 | 24,164 | Common Stock |
Guardion Health Sciences Inc | Bret Scholtes | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 30 Aug 2021 | 5,500 | 179,484 (0%) | 0% | 1.2 | 6,760 | Common stock |
Guardion Health Sciences Inc | Bret Scholtes | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 30 Aug 2021 | 4,500 | 173,984 (0%) | 0% | 1.3 | 5,656 | Common stock |
Guardion Health Sciences Inc | Bret Scholtes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 916,023 | 916,023 | - | - | Employee Stock Option (right to buy) |